EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that the US Food and Drug Administration (FDA) has approved its orphan drug ERWINAZE™ (asparaginase Erwinia ... FDA approves EUSA's orphan drug ERWINAZE for acute lymphoblastic leukemia
Friday, November 18, 2011
FDA approves EUSA's orphan drug ERWINAZE for acute lymphoblastic leukemia
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that the US Food and Drug Administration (FDA) has approved its orphan drug ERWINAZE™ (asparaginase Erwinia ... FDA approves EUSA's orphan drug ERWINAZE for acute lymphoblastic leukemia
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment